The apelinergic system, consisting of the apelin receptor (APJ) and its cognate ligand apelin, is active in pancreas, skeletal muscle, adipose and other tissues. Apelin/APJ are implicated in energy metabolism as apelin is secreted by adipocytes and may bind APJ on β-cell membranes to reduce glucose-stimulated insulin secretion. Apelin-13 administration has been shown to increase islet cell mass and β-cell insulin content in mice with T1DM and can increase insulin sensitivity in obese, hyperinsulinaemic mice. The metabolic stress of pregnancy is normally accommodated by β-cell mass (BCM) expansion and increased glucose-stimulated insulin secretion. A failure to increase BCM can contribute to the risk of gestational diabetes. Exposure of mice to a low protein diet (LP) in utero can limit expansion of BCM during subsequent pregnancy. As previously shown, insulin-expressing but glucose-transporter-2-low (Ins+Glut2Lo) progenitor cells contribute to gestational BCM expansion. Thus, we investigated how APJ presence on Ins+Glut2Lo cells might differ in islets of pregnant C57Bl/6 mice previously exposed to LP vs. control (C) diet. F1 female offspring exposed to LP or C diet in utero and postnatal development were time mated and pancreata collected at gestational days (GD) 9 and 12. Insulin, Glut2, and APJ were visualized by immunohistochemistry with respect to β-cell localization in small endocrine clusters (1-5 β-cells) and in islets (≥ 6 β-cells). The percentage of Ins+Glut2LoAPJ+ cells relative to all Ins+ cells was significantly decreased in LP-exposed mice vs. C at GD12 (C 5.7±1.0%, LP 2.7±0.1%, p<0.05) when Ins+Glut2Lo cell expansion is maximal, but not at GD9 (C 4.9±1.6%, LP 3.4±0.9%). Significant differences were not found in % Ins+Glut2LoAPJ+ cells relative to extra-islet clusters or islets between LP vs. C at GD 9 and 12. Results suggest that APJ presence may contribute to BCM expansion during pregnancy mediated by Ins+Glut2Lo cells.

Disclosure

H. Azimi: None. S. Szlapinski: None. D.J. Hill: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.